Dementia is a metabolic disease, not a genetic one. Here's what's really destroying your brain, and how to reverse it. Dr. Anthony Chaffee MD.
generated summary
Brain evolution and fuel
- Human cranial-capacity analyses found a reduction of about 10-17% from the Mesolithic to modern times, while domesticated pigs had brains about 18% smaller than wild boars.[1][2]
- Dementia and neurodegeneration are largely preventable consequences of chronic shortages of ketones, cholesterol, and animal nutrients together with exposure to sugar and seed oils.
- Human fasting studies found that rising ketone availability lowers cerebral glucose use and supplies a major share of brain energy.[3][4]
- The neonatal period depends heavily on ketone metabolism; germline loss of ketone oxidation causes fatal postnatal metabolic failure in mice.[5]
- Pregnancy accelerates fasting ketosis, and breast-fed infants generate more ketones than formula-fed infants.[6][7]
Animal nutrients and brain maintenance
- Cholesterol, saturated fat, B12, D3, vitamin A, choline, creatine, carnitine, and DHA supply structural and metabolic materials for myelin, synapses, membranes, and mitochondria.
- An 18-person Alzheimer pilot found cognition improved after six weeks off statins and declined after six weeks back on them.[8]
- Severe infant B12 deficiency causes developmental regression and MRI-visible cerebral atrophy.[9]
- Lower B12 markers within conventional ranges predict faster brain-volume loss over five years.[10]
- Low maternal B12 intake during pregnancy predicts poorer speech and mathematical performance through childhood.[11]
- Adolescents raised on macrobiotic diets can retain marginal B12 status and cognitive deficits after changing to omnivorous diets.[12]
Aging and dietary injury
- MRI comparisons found age-related cerebral shrinkage in humans but not across 99 chimpanzees.[13]
- Long-lived whales and wild animals on natural diets do not show the same age-related brain shrinkage, making chronic malnutrition a better explanation than normal aging.
- Fructose, excess linoleic acid, brain insulin resistance, glycation, vitamin D deficiency, and inadequate DHA, EPA, creatine, carnitine, and vitamin A converge on mitochondrial dysfunction and neuroinflammation.
- Porphyromonas gingivalis antigens were detected in most examined Alzheimer brains and in a high proportion of glioblastoma tissue cores.[14][15]
Ketogenic interventions
- A randomized childhood epilepsy trial found substantial seizure reduction with a ketogenic diet.[16]
- Alzheimer brains retain acetoacetate metabolism despite reduced glucose uptake, and a randomized ketogenic-diet trial found improvement in clinical outcomes.[17][18]
- Randomized ketogenic and Mediterranean diet studies both improved Parkinson symptoms, with greater nonmotor improvement in the ketogenic trial.[19][20]
- Early autism data and a Huntington case study link ketogenic diets with functional improvement.[21][22]
- A multiple-sclerosis case series with symptom improvement and MRI lesion shrinkage is being prepared for publication.
Genetic risk and prevention
- In a 15-year cohort of 2,157 older adults, high meat intake was associated with slower cognitive decline and lower dementia risk among APOE epsilon-4 carriers.[23]
- Genes modify susceptibility, but correcting brain fuel and nutrient supply can prevent or reduce the metabolic conditions that drive neurodegeneration.
References
- [00:09] Decrease of Human Skull Size in the Holocene — https://digitalcommons.wayne.edu/humbiol/vol60/iss3/5
- [00:21] How domestication, feralization and experience-dependent plasticity affect brain size variation in Sus scrofa — https://doi.org/10.1098/rsos.240951
- [01:07] Generalized decrease in brain glucose metabolism during fasting in humans studied by PET — https://doi.org/10.1152/ajpendo.1989.256.6.E805
- [01:24] Brain Metabolism during Fasting — https://doi.org/10.1172/JCI105650
- [01:49] Obligate Role for Ketone Body Oxidation in Neonatal Metabolic Homeostasis — https://doi.org/10.1074/jbc.M110.192369
- [02:04] "Accelerated starvation" and the skipped breakfast in late normal pregnancy — https://doi.org/10.1016/S0140-6736(82)91750-0
- [02:55] Higher Serum Carnitine Levels and Ketogenesis in Breast Fed as Compared to Formula Fed Infants — https://doi.org/10.1203/00006450-197804001-00848
- [04:51] The effect of HMG-CoA reductase inhibitors on cognition in patients with Alzheimer's dementia: a prospective withdrawal and rechallenge pilot study — https://doi.org/10.1016/j.amjopharm.2012.08.002
- [06:29] Cerebral atrophy in 21 hypotonic infants with severe vitamin B12 deficiency — https://doi.org/10.1111/jpc.14733
- [06:45] Vitamin B12 status and rate of brain volume loss in community-dwelling elderly — https://doi.org/10.1212/01.wnl.0000325581.26991.f2
- [07:48] Maternal prenatal vitamin B12 intake is associated with speech development and mathematical abilities in childhood — https://doi.org/10.1016/j.nutres.2020.12.005
- [08:18] Signs of impaired cognitive function in adolescents with marginal cobalamin status — https://doi.org/10.1093/ajcn/72.3.762
- [08:50] Aging of the cerebral cortex differs between humans and chimpanzees — https://doi.org/10.1073/pnas.1016709108
- [11:02] Porphyromonas gingivalis in Alzheimer's disease brains: Evidence for disease causation and treatment with small-molecule inhibitors — https://doi.org/10.1126/sciadv.aau3333
- [11:22] Identification of gingipains in glioblastoma tumors and evidence that P. gingivalis infection drives IL-6 and PD-L1 expression in glioma cells — https://doi.org/10.1101/2025.11.13.686868
- [12:20] The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial — https://doi.org/10.1016/S1474-4422(08)70092-9
- [12:34] Lower Brain 18F-Fluorodeoxyglucose Uptake But Normal 11C-Acetoacetate Metabolism in Mild Alzheimer's Disease Dementia — https://doi.org/10.3233/JAD-141074
- [12:45] Randomized crossover trial of a modified ketogenic diet in Alzheimer's disease — https://doi.org/10.1186/s13195-021-00783-x
- [12:55] Low-fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial — https://doi.org/10.1002/mds.27390
- [13:07] The effects of Mediterranean diet on severity of disease and serum Total Antioxidant Capacity in patients with Parkinson's disease — https://doi.org/10.1080/1028415X.2020.1751509
- [13:41] A modified ketogenic gluten-free diet with MCT improves behavior in children with autism spectrum disorder — https://doi.org/10.1016/j.physbeh.2018.02.006
- [14:01] Time-Restricted Ketogenic Diet in Huntington's Disease: A Case Study — https://doi.org/10.3389/fnbeh.2022.931636
- [14:56] Meat Consumption and Cognitive Health by APOE Genotype — https://doi.org/10.1001/jamanetworkopen.2026.6489
GPT-5.6 Thinking - high
5.6 extra summary
Brain-Size Reduction and the Origin of Dementia
For more than two million years the human brain increased in size, but during the last several thousand years it shrank by 10–17% in both men and women in parallel with a dietary shift away from meat and animal fat toward grain.[1,2] Grain-fed domestic pigs likewise have brains 18% smaller than wild boars.[3]
Dementia and neurodegeneration are not inevitable consequences of genes or aging. They are predictable results of starving and poisoning the brain and can be 100% preventable.
Ketones as the Brain’s Preferred Fuel
The brain preferentially uses ketones and fat when they are available. It uses glucose only after ketones are exhausted, apart from the smaller proportion of brain cells that continue using some glucose. The vast majority of the brain runs exclusively on ketones for as long as they remain available.
Human PET studies show that glucose uptake falls in Alzheimer’s disease and during deeper ketosis, while ketones can supply 60–70% of brain energy even when glucose remains available at normal concentrations.[4–6]
Ketones During Fetal and Infant Development
The neonatal brain is built for a ketogenic environment. Removing either ketones or the ability to metabolize them in animal models produces catastrophic energy failure despite normal glucose, preventing normal brain development, growth and function.[7,8]
Pregnancy produces “accelerated starvation,” particularly during the third trimester, allowing pregnant women to enter ketosis more readily.[9] Maternal ketones cross the placenta, supply the developing fetus, and are reconstituted into the fatty acids that form the physical structure of the brain.[10–12] The rapidly growing fetal brain therefore needs as much ketone and fat as the mother can provide.
Breast milk is deliberately ketogenic. Breast-fed infants produce ketones despite the lactose in human milk, while formula-fed infants have substantially lower ketone concentrations.[13] The human brain is designed to run on fat and ketones and to be built from cholesterol and saturated fat rather than constant dietary glucose and seed oils.
Cholesterol, Myelin and Synapses
Although the brain represents about 2% of body weight, it contains more than 25% of the body’s cholesterol. Cholesterol provides brain structure and is rate-limiting for myelin and synapse formation. Lower cholesterol means fewer synapses and neural connections, impaired myelin development and slower neuronal conductivity.[14]
Statins and Brain Cholesterol
Fat-soluble statins cross the blood–brain barrier, suppress cholesterol synthesis within the brain and can cause iatrogenic neurodegeneration.[15] Brain cholesterol is produced behind the blood–brain barrier and does not enter the circulation, so suppressing its synthesis slows and damages the brain without affecting arterial cholesterol.
FDA labeling recognizes statin-associated memory and cognitive problems.[16] In a withdrawal-and-rechallenge study involving 18 Alzheimer’s patients, cognition improved after statins were stopped and declined again after treatment resumed, demonstrating a reversible statin effect on cognition.[17]
Animal Nutrients as Brain-Building Materials
B12, vitamin D3, preformed vitamin A, choline, creatine, carnitine, DHA, saturated fat and cholesterol come exclusively or primarily from animal foods and are necessary for brain development, function and maintenance.
These nutrients are core materials for:
Removing animal products removes most of the raw materials from which the brain is constructed and can only lead to brain damage and neurodegeneration if it continues.
B12 Deficiency, Brain Atrophy and Development
Severe B12 deficiency in infants causes cerebral atrophy, delayed myelination, seizures and lasting cognitive damage, even when structural abnormalities improve after B12 replacement.[18]
Damage begins before overt deficiency. Older adults with lower B12 values inside the normal range experience faster brain atrophy, while higher B12 predicts slower or absent loss.[19] The lower portion of the normal range was associated with approximately 2.5–5.1% brain-volume loss over five years.[19]
Current normal ranges are population averages drawn from a population obtaining approximately 70% of its calories from plants, principally carbohydrates. Because plants contain no B12, these averages conceal widespread deficiency.
Maternal B12 intake during pregnancy is associated with children’s later speech, vocabulary and mathematical performance. Children whose mothers were in the bottom tenth of B12 intake performed worse for as long as the study followed them, despite maternal intake remaining within the normal range.[20]
Children raised on vegan or macrobiotic diets can retain marginal B12 status and cognitive deficits even after changing to an omnivorous diet.[21]
Human Brain Shrinkage Is Not Normal Aging
Age-related brain shrinkage should not be considered normal. In a comparative imaging study, human brains shrank predictably with age while chimpanzee brains did not.[22]
The difference is dietary: chimpanzees continue eating the food for which they are designed, while humans deprive the brain of required nutrients and expose it to harmful substances. Whales can live for approximately 200 years without developing the same neurodegeneration, and no wild animal eating its natural diet has been shown to undergo progressive age-related brain shrinkage.
What is described as normal age-related cerebral atrophy may instead be the brain’s response to chronic multidecade malnutrition.
Fructose, Seed Oils and Neuroinflammation
Modern diets both starve and poison the brain.
Fructose drives:
These fructose-related pathways damage brain metabolism and function.[23–25]
Excess omega-6 seed oils and linoleic acid promote oxidative stress and chronic neuroinflammation.[26,27]
Vitamin D and Missing Protective Nutrients
Insufficient sunlight, avoidance of fat and cholesterol, and statin use impair vitamin D synthesis. Vitamin D deficiency alters brain development and increases dementia risk.[28–30]
Plant-only diets lack DHA, EPA, carnitine, creatine and preformed vitamin A, undermining brain development and repair.
Oral Pathogens and Brain Disease
Carbohydrate consumption promotes oral conditions that allow Porphyromonas gingivalis to proliferate, enter the body and damage the heart and brain.
Gingipain evidence was found in up to 96% of examined Alzheimer’s brains.[31] Core biopsies likewise detected evidence of P. gingivalis in 89% of glioblastomas.[32]
The organism survives in the mouth through Candida, which itself depends on dietary carbohydrate.[33] Modern diets therefore supply the brain with toxic inputs while withholding substances it cannot function without.
Epilepsy
Ketogenic treatment demonstrates that changing the brain’s fuel changes neurological disease. Ketogenic diets have treated epilepsy for approximately a century and remain a standard treatment for drug-resistant epilepsy.
Randomized trials show seizure reductions exceeding 50% in approximately half of treated patients.[34]
Alzheimer’s Disease
Alzheimer’s disease is now described as type 3 diabetes because of impaired insulin signaling and glucose metabolism in the brain.[35,36]
PET imaging shows reduced cerebral glucose uptake with preserved ketone uptake, meaning that an Alzheimer’s brain can continue running on ketones.[6] Randomized trials consequently show that ketogenic diets produce better Alzheimer’s outcomes than every medication that has been trialed.[37]
Parkinson’s Disease
Randomized trials in Parkinson’s disease show significant improvements in both motor and nonmotor deficits with ketogenic diets, with nonmotor improvements exceeding those achieved with a healthy Mediterranean diet.[38]
A healthier conventional diet can improve Parkinson’s disease, but a ketogenic diet improves it further.
Multiple Sclerosis
People with multiple sclerosis have experienced major symptomatic improvements and reductions in MRI-visible lesions beyond those achieved with medication.
A forthcoming case series documents near-miraculous clinical and radiological recoveries.
Autism
Early autism data show improvements with ketogenic diets such as a carnivore diet containing abundant meat, animal fat, carnitine and other nutrients required by neurons and mitochondria.[39–41]
Some clinics use ketogenic diets as a principal autism treatment.
Huntington’s Disease
A Huntington’s disease case report documented motor and functional improvements exceeding drug therapy during a ketogenic intervention.[42]
A Shared Upstream Metabolic Failure
Epilepsy, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, autism and Huntington’s disease are not being treated by unrelated diets.
The same intervention corrects a shared upstream metabolic failure expressed through different neural vulnerabilities. It supplies essential nutrients and removes damaging inputs.
The modern dementia epidemic is a preventable brain crisis caused by decades of depriving the brain of ketones, cholesterol and animal nutrients while supplying sugar and seed oils.
5.6 extra summary/references
APOE4 and Dietary Protection
Genetic predisposition does not make dementia inevitable. Among APOE4 carriers, people in the highest category of meat consumption—more than approximately 800 grams per week—were protected against the genotype’s effects and had no increased dementia risk in that study.[43]
Diet can neutralize or amplify genetic susceptibility. Even the strongest genetic risk often disappears when people eat a high-fat, meat-based ketogenic species-appropriate diet.
References
Stibel HD. Decreases in Brain Size and Encephalization in Anatomically Modern Humans. Brain, Behavior and Evolution. 2021.
https://doi.org/10.1159/000519504
DeSilva JM, Traniello JFA, Claxton AG, Fannin LD. When and Why Did Human Brains Decrease in Size? A New Change-Point Analysis and Insights From Brain Evolution in Ants. Frontiers in Ecology and Evolution. 2021.
https://doi.org/10.3389/fevo.2021.742639
Cucchi T, Neaux D, Féral L, et al. How Domestication, Feralization and Experience-Dependent Plasticity Affect Brain Size Variation in Sus scrofa. Royal Society Open Science. 2024.
https://doi.org/10.1098/rsos.240951
Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GF Jr. Brain Metabolism During Fasting. Journal of Clinical Investigation. 1967.
https://doi.org/10.1172/JCI105650
Courchesne-Loyer A, Croteau E, Castellano CA, et al. Inverse Relationship Between Brain Glucose and Ketone Metabolism in Adults During Short-Term Moderate Dietary Ketosis: A Dual-Tracer Quantitative Positron Emission Tomography Study. Journal of Cerebral Blood Flow & Metabolism. 2017.
https://doi.org/10.1177/0271678X16669366
Castellano CA, Nugent S, Paquet N, et al. Lower Brain 18F-Fluorodeoxyglucose Uptake but Normal 11C-Acetoacetate Metabolism in Mild Alzheimer’s Disease Dementia. Journal of Alzheimer’s Disease. 2015.
https://doi.org/10.3233/JAD-141074
Cotter DG, Schugar RC, Crawford PA. Obligate Role for Ketone Body Oxidation in Neonatal Metabolic Homeostasis. Journal of Biological Chemistry. 2011.
https://doi.org/10.1074/jbc.M110.192369
Enders A, Ding Y, Plasschaert LW, et al. Ketolysis Is Required for Proper Development and Function of the Somatosensory Nervous System. Experimental Neurology. 2023.
https://doi.org/10.1016/j.expneurol.2023.114428
Metzger BE, Vileisis RA, Ravnikar V, Freinkel N. “Accelerated Starvation” and the Skipped Breakfast in Late Normal Pregnancy. The Lancet. 1982.
https://doi.org/10.1016/S0140-6736(82)91750-0
Herrera E. Lipid Metabolism in Pregnancy and Its Consequences in the Fetus and Newborn. Endocrine. 2002.
https://doi.org/10.1385/ENDO:19:1:43
Yeh YY, Streuli VL. Ketone Bodies Serve as Important Precursors of Brain Lipids in the Developing Rat. Lipids. 1977.
https://doi.org/10.1007/BF02533318
Edmond J. Ketone Bodies as Precursors of Sterols and Fatty Acids in the Developing Rat. Journal of Biological Chemistry. 1974.
https://doi.org/10.1016/S0021-9258(19)43092-5
Warshaw JB, Curry E. Comparison of Serum Carnitine and Ketone Body Concentrations in Breast- and Formula-Fed Newborn Infants. Journal of Pediatrics. 1980.
https://doi.org/10.1016/S0022-3476(80)80151-X
Björkhem I, Meaney S. Brain Cholesterol: Long Secret Life Behind a Barrier. Arteriosclerosis, Thrombosis, and Vascular Biology. 2004.
https://doi.org/10.1161/01.ATV.0000120374.59826.1b
Cibičková L. Statins and Their Influence on Brain Cholesterol. Journal of Clinical Lipidology. 2011.
https://doi.org/10.1016/j.jacl.2011.06.007
US Food and Drug Administration. Lipitor (Atorvastatin Calcium) Prescribing Information: Postmarketing Cognitive Impairment Reports. 2014.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020702s064lbl.pdf
Padala KP, Padala PR, McNeilly DP, Geske JA, Sullivan DH, Potter JF. The Effect of HMG-CoA Reductase Inhibitors on Cognition in Patients With Alzheimer’s Dementia: A Prospective Withdrawal and Rechallenge Pilot Study. American Journal of Geriatric Pharmacotherapy. 2012.
https://doi.org/10.1016/j.amjopharm.2012.08.002
Lövblad KO, Ramelli G, Remonda L, et al. Retardation of Myelination Due to Dietary Vitamin B12 Deficiency: Cranial MRI Findings. Pediatric Radiology. 1997.
https://doi.org/10.1007/s002470050090
Vogiatzoglou A, Refsum H, Johnston C, et al. Vitamin B12 Status and Rate of Brain Volume Loss in Community-Dwelling Elderly. Neurology. 2008.
https://doi.org/10.1212/01.wnl.0000325581.26991.f2
Golding J, Gregory S, Clark R, et al. Maternal Prenatal Vitamin B12 Intake Is Associated With Speech Development and Mathematical Abilities in Childhood. Nutrition Research. 2021.
https://doi.org/10.1016/j.nutres.2020.12.005
Louwman MWJ, van Dusseldorp M, van de Vijver FJR, et al. Signs of Impaired Cognitive Function in Adolescents With Marginal Cobalamin Status. American Journal of Clinical Nutrition. 2000.
https://doi.org/10.1093/ajcn/72.3.762
Sherwood CC, Gordon AD, Allen JS, et al. Aging of the Cerebral Cortex Differs Between Humans and Chimpanzees. Proceedings of the National Academy of Sciences. 2011.
https://doi.org/10.1073/pnas.1016709108
Spagnuolo MS, Iossa S, Cigliano L. Sweet but Bitter: Focus on Fructose Impact on Brain Function in Rodent Models. Nutrients. 2021.
https://doi.org/10.3390/nu13010001
Johnson RJ, Gomez-Pinilla F, Nagel M, et al. Cerebral Fructose Metabolism as a Potential Mechanism Driving Alzheimer’s Disease. Frontiers in Aging Neuroscience. 2020.
https://doi.org/10.3389/fnagi.2020.560865
Li JM, Ge CX, Xu MX, et al. Betaine Recovers Hypothalamic Neural Injury by Inhibiting Astrogliosis and Inflammation in Fructose-Fed Rats. Molecular Nutrition & Food Research. 2015.
https://doi.org/10.1002/mnfr.201400307
Taha AY, Blanchard HC, Cheon Y, et al. Dietary Linoleic Acid Lowering Reduces Lipopolysaccharide-Induced Increase in Brain Arachidonic Acid Metabolism. Molecular Neurobiology. 2017.
https://doi.org/10.1007/s12035-016-9968-1
Taha AY. Linoleic Acid—Good or Bad for the Brain? npj Science of Food. 2020.
https://doi.org/10.1038/s41538-019-0061-9
Dawson-Hughes B, Harris SS, Lichtenstein AH, Dolnikowski G, Palermo NJ, Rasmussen H. Dietary Fat Increases Vitamin D3 Absorption. Journal of the Academy of Nutrition and Dietetics. 2015.
https://doi.org/10.1016/j.jand.2014.09.014
Janbek J, Specht IO, Heitmann BL. Associations Between Vitamin D Status in Pregnancy and Offspring Neurodevelopment: A Systematic Literature Review. Nutrition Reviews. 2019.
https://doi.org/10.1093/nutrit/nuy071
Jayedi A, Rashidy-Pour A, Shab-Bidar S. Vitamin D Status and Risk of Dementia and Alzheimer’s Disease: A Meta-Analysis of Dose-Response. Nutritional Neuroscience. 2019.
https://doi.org/10.1080/1028415X.2018.1436639
Dominy SS, Lynch C, Ermini F, et al. Porphyromonas gingivalis in Alzheimer’s Disease Brains: Evidence for Disease Causation and Treatment With Small-Molecule Inhibitors. Science Advances. 2019.
https://doi.org/10.1126/sciadv.aau3333
Moore EM, Bekale LA, Tun ZMM, et al. Identification of Gingipains in Glioblastoma Tumors and Evidence That P. gingivalis Infection Drives IL-6 and PD-L1 Expression in Glioma Cells. bioRxiv. 2025.
https://doi.org/10.1101/2025.11.13.686868
Bartnicka D, Karkowska-Kuleta J, Zawrotniak M, et al. Adhesive Protein-Mediated Cross-Talk Between Candida albicans and Porphyromonas gingivalis in Dual-Species Biofilm Protects the Anaerobic Bacterium in an Unfavorable Oxic Environment. Scientific Reports. 2019.
https://doi.org/10.1038/s41598-019-40771-8
Neal EG, Chaffe H, Schwartz RH, et al. The Ketogenic Diet for the Treatment of Childhood Epilepsy: A Randomised Controlled Trial. The Lancet Neurology. 2008.
https://doi.org/10.1016/S1474-4422(08)70092-9
Steen E, Terry BM, Rivera EJ, et al. Impaired Insulin and Insulin-Like Growth Factor Expression and Signaling Mechanisms in Alzheimer’s Disease—Is This Type 3 Diabetes? Journal of Alzheimer’s Disease. 2005.
https://doi.org/10.3233/JAD-2005-7107
de la Monte SM, Wands JR. Alzheimer’s Disease Is Type 3 Diabetes—Evidence Reviewed. Journal of Diabetes Science and Technology. 2008.
https://doi.org/10.1177/193229680800200619
Phillips MCL, Deprez LM, Mortimer GMN, et al. Randomized Crossover Trial of a Modified Ketogenic Diet in Alzheimer’s Disease. Alzheimer’s Research & Therapy. 2021.
https://doi.org/10.1186/s13195-021-00783-x
Phillips MCL, Murtagh DKJ, Gilbertson LJ, Asztely FJS, Lynch CDP. Low-Fat Versus Ketogenic Diet in Parkinson’s Disease: A Pilot Randomized Controlled Trial. Movement Disorders. 2018.
https://doi.org/10.1002/mds.27390
Evangeliou A, Vlachonikolis I, Mihailidou H, et al. Application of a Ketogenic Diet in Children With Autistic Behavior: Pilot Study. Journal of Child Neurology. 2003.
https://doi.org/10.1177/08830738030180020501
El-Rashidy O, El-Baz F, El-Gendy Y, et al. Ketogenic Diet Versus Gluten-Free Casein-Free Diet in Autistic Children: A Case-Control Study. Metabolic Brain Disease. 2017.
https://doi.org/10.1007/s11011-017-0088-z
Lee RWY, Corley MJ, Pang A, et al. A Modified Ketogenic Gluten-Free Diet With MCT Improves Behavior in Children With Autism Spectrum Disorder. Physiology & Behavior. 2018.
https://doi.org/10.1016/j.physbeh.2018.02.006
Phillips MCL, McManus EJ, Brinkhuis M, Romero-Ferrando B. Time-Restricted Ketogenic Diet in Huntington’s Disease: A Case Study. Frontiers in Behavioral Neuroscience. 2022.
https://doi.org/10.3389/fnbeh.2022.931636
Norgren J, Carballo-Casla A, Grande G, et al. Meat Consumption and Cognitive Health by APOE Genotype. JAMA Network Open. 2026.
https://doi.org/10.1001/jamanetworkopen.2026.6489